Literature DB >> 9565656

Transgene expression kinetics after transfection with cationic phosphonolipids in hematopoietic non adherent cells.

V Floch1, M P Audrezet, C Guillaume, E Gobin, G Le Bolch, J C Clement, J J Yaouanc, H Des Abbayes, B Mercier, J P Leroy, J F Abgrall, C Ferec.   

Abstract

Cationic lipids are considered to be capable of efficiently and safely mediating DNA transfer into cells, although expression is transient. A new family of cationic lipids, called phosphonolipids, has been developed, with the relationship between the hydrophobic domain of the lipid molecules and the significant enhancement of transduction efficiency in a non-adherent cell line characterised in the present study. The kinetics of transfection efficiency were also investigated. Our results demonstrate that the peak of the transient expression of these reporter genes mediated by cationic lipids occurred within 3 to 14 days, depending on the aliphatic chain length of the complex used and on its formulation in the presence or absence of DOPE. Furthermore, the kinetics of transgene expression were found to differ in adherent and non-adherent cells. These results were obtained using three different techniques: CPRG, luminescence, and FACS-gal, and were in agreement with electron microscopy studies. We thus hypothesized that the plasma membrane composition of cells could affect the efficiency of transfection with cationic lipids. Our results suggest that phosphonolipids constitute a promising class of compounds for gene transfer protocols, and that galenic optimization should improve and modify the transfection efficiency of these DNA-lipid complexes. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9565656     DOI: 10.1016/s0005-2736(98)00002-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipids.

Authors:  Tristan Montier; Pascal Delépine; Rémi Marianowski; Karine Le Ny; Morgane Le Bris; Danielle Gillet; Gaël Potard; Philippe Mondine; Irène Frachon; Jean-Jacques Yaouanc; Jean-Claude Clément; Harvé Des Abbayes; Claude Férec
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.860

Review 2.  CAR-NK cells: A promising cellular immunotherapy for cancer.

Authors:  Guozhu Xie; Han Dong; Yong Liang; James Dongjoo Ham; Romee Rizwan; Jianzhu Chen
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.